Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Bintou Fane"'
Autor:
Ousmane Kodio, Antieme Combo Georges Togo, Yeya dit Sadio Sarro, Bintou Fane, Fatimata Diallo, Amadou Somboro, Boureima Degoga, Mahamadou Kone, Gagni Coulibaly, Mohamed Tolofoudje, Sidy Bane, Moumine Sanogo, Bourahima Kone, Nadie Coulibaly, Djeneba Dabitao, Bocar Baya, Mamoudou Maiga, Flabou Bougoudogo, Fasse Samake, Sounkalo Dao, Seydou Doumbia, Souleymane Diallo, Bassirou Diarra
Publikováno v:
International Journal of Mycobacteriology, Vol 8, Iss 3, Pp 287-291 (2019)
Background: While, bacteria resistance mutations can affect competitive fitness, given our multidrug-resistant (MDR) prevalence, we conducted this study to determine the impact of MDR on the competitive fitness of Mycobacterium tuberculosis (MTB) com
Externí odkaz:
https://doaj.org/article/c913120e0bf445eb8a5db86d1fc42d2b
Autor:
Mohamed Tolofoudje, Bocar Baya, Yeya dit Sadio Sarro, Sidy Bane, Bourahima Kone, Souleymane Diallo, Ousmane Kodio, Djeneba Dabitao, Moumine Sanogo, Bintou Fane, Gagni Coulibaly, Mamoudou Maiga, Nadie Coulibaly, Boureima Degoga, Fasse Samake, Bassirou Diarra, Fatimata Diallo, Mahamadou Kone, Sounkalo Dao, Seydou Doumbia, F Bougoudogo, Amadou Somboro, Antieme Combo Georges Togo
Publikováno v:
International journal of mycobacteriology
International Journal of Mycobacteriology, Vol 8, Iss 3, Pp 287-291 (2019)
International Journal of Mycobacteriology, Vol 8, Iss 3, Pp 287-291 (2019)
Background: While, bacteria resistance mutations can affect competitive fitness, given our multidrug-resistant (MDR) prevalence, we conducted this study to determine the impact of MDR on the competitive fitness of Mycobacterium tuberculosis (MTB) com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2aeaff799d06ad7a9c0407538e8371a
http://europepmc.org/articles/PMC6918047
http://europepmc.org/articles/PMC6918047
Autor:
Bocar Baya, Yeya dit Sadio Sarro, B Aissata, Bouke C. de Jong, Amadou Somboro, Robert L. Murphy, Tom Decroo, Seydou Doumbia, Fatimata Diallo, Armand Van Deun, Bintou Fane, Affolabi Dissou, Marie Laure Keita, Gagni Coulibaly, Bassirou Diarra, Leen Rigouts, Suzanne Orsega, Boureima Degoga, Souleymane Diallo
Publikováno v:
BMJ Global Health. 4:A51.3-A52
IntroductionXpert MTB/RIF assay is used extensively for the detection of rifampicin-resistant TB (RR-TB). RR-TB treatment monitoring is culture-based, although, in resource-limited settings, access to TB culture is poor. Alternative methods are neede
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2b729fb079efda68171e487023b66421
https://doi.org/10.1136/bmjgh-2019-edc.135
https://doi.org/10.1136/bmjgh-2019-edc.135